Literature DB >> 29168622

Mitral valve pressure gradient after percutaneous mitral valve repair: every beat counts.

Daniel Lavall1, Bruno Scheller1, Christian Werner1, Axel Buob1, Felix Mahfoud1.   

Abstract

A patient presented with symptoms of decompensated heart failure 2 months after percutaneous mitral valve (MV) repair. Echocardiography demonstrated impaired left ventricular function with elevated MV pressure gradients and pulmonary pressures during rapid atrial fibrillation. Heart rate control was achieved by implantation of a biventricular pacemaker with subsequent His-bundle ablation because atrial fibrillation was refractory to medical treatment. During biventricular pacing at different rates (50-110 b.p.m.), heart rate correlated positively with both MV mean pressure gradient and global longitudinal strain and negatively with stroke volume. MV pressure gradients directly translated into elevated pulmonary pressures. Thus, rate control and biventricular pacing improved cardiac haemodynamics.
© 2017 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.

Entities:  

Keywords:  Global longitudinal strain; Heart rate; Mitral valve pressure gradient; Percutaneous mitral valve repair; Pulmonary pressures

Mesh:

Year:  2017        PMID: 29168622      PMCID: PMC5793967          DOI: 10.1002/ehf2.12238

Source DB:  PubMed          Journal:  ESC Heart Fail        ISSN: 2055-5822


Introduction

Percutaneous mitral valve repair (PMVR) has emerged as a treatment alternative for patients with primary and secondary severe mitral regurgitation (MR) and high or prohibitive surgical risk. Successful PMVR can improve cardiac haemodynamics1, 2 and quality of life.3 However, mortality remains substantial after PMVR, and re‐hospitalizations for heart failure occur in up to one‐fourth of patients within 1 year.4, 5, 6 Echocardiography plays a key role in the evaluation of patients admitted for heart failure,7 and even more in patients with prior mitral valve (MV) interventions. Particularly, MV function has to be assessed rigorously regarding recurrent regurgitation or stenosis due to reduced MV orifice following clip implantation. We report the case of a patient who presented with cardiac decompensation due to worsening MV haemodynamics during rapid atrial fibrillation (AF) after recent PMVR.

Case report

A 76‐year‐old female patient presented to the emergency department with signs and symptoms of acute decompensated heart failure. She suffered from progressive dyspnoea on exertion and recently also at rest. Two months prior to admission, the patient underwent PMVR with MitraClip implantation due to symptomatic severe MR of combined degenerative and functional aetiology. Coronary artery disease was excluded before PMVR, left ventricular ejection fraction (LVEF) was 54%, and the rhythm was permanent AF with normal heart rate (HR). Two clips were deployed in a medial position to achieve complete resolution of MR with a mean MV pressure gradient (MVPG) of 5 mmHg at the end of the procedure. Echocardiography revealed an LVEF of 43% after PMVR. Electrocardiography on admission showed left bundle branch block and AF with an average HR of 100–110 b.p.m., despite treatment with maximal dose of beta‐blockers and digoxin. Chest X‐ray confirmed pulmonary congestion. Echocardiography documented an LVEF of 37% with signs of LV dyssynchrony, a mean MVPG of 12 mmHg with a right ventricular systolic pressure (RVSP) of 43 mmHg. Both MitraClips were in situ, and only mild MR was present. Permanent AF and a newly diagnosed thrombus in the left atrial appendage prohibited electrical and pharmacological cardioversion for rate control. Therefore, implantation of a biventricular pacemaker and subsequent His‐bundle ablation were performed. A comprehensive echocardiographic study was performed in a stable, compensated clinical condition 7 days after His‐bundle ablation. Cardiac haemodynamics were assessed under biventricular stimulation at different pacing rates (50–110 b.p.m.) in VVI mode with an interventricular (V‐V) delay of 0 ms. LVEF improved to 49% at an HR of 70 b.p.m. during biventricular pacing. With increasing ventricular pacing frequency, there was a linear increase in mean MVPG (Figure A) and RVSP (Figure B). An increase in HR was associated with a decrease in stroke volume (Figure C), whereas cardiac output (Figure D) remained similar. Global longitudinal strain (GLS) correlated positively with HR (Figure E). The MVPG correlated directly with RVSP, i.e. pulmonary pressures (Figure F). Finally, the lower frequency limit was set at 60 b.p.m., resulting in a cardiac output of 2.5 L/min with a mean MVPG of 5.8 mmHg and a RVSP of 27 mmHg.
Figure 1

Correlation between heart rate and key haemodynamic measurements derived from echocardiography. Heart rate (HR) correlates with (A) mean mitral valve pressure gradient (MVPG), (B) right ventricular systolic pressure (RVSP), (C) stroke volume (SV), (D) cardiac output (CO), and (E) global longitudinal strain (GLS). (F) Correlation of MVPG with RVSP. The lines represent the non‐linear regression curve. Pearson correlation coefficients were computed. P‐values < 0.05 were considered to be statistically significant.

Correlation between heart rate and key haemodynamic measurements derived from echocardiography. Heart rate (HR) correlates with (A) mean mitral valve pressure gradient (MVPG), (B) right ventricular systolic pressure (RVSP), (C) stroke volume (SV), (D) cardiac output (CO), and (E) global longitudinal strain (GLS). (F) Correlation of MVPG with RVSP. The lines represent the non‐linear regression curve. Pearson correlation coefficients were computed. P‐values < 0.05 were considered to be statistically significant.

Discussion

Cardiac haemodynamics typically improve early after PMVR in both primary and secondary MR.1 Successful MR reduction during PMVR is associated with prognosis, as procedural failure has been identified as one of the strongest predictor for death.1 There is a slight increase in both HR and MVPG after PMVR by its edge‐to‐edge repair principle creating a double orifice valve.1 The increase in HR might be an acute physiological response to maintain left ventricular filling through a smaller MV orifice area until chronic adaptation occurs. Unfortunately, in this case, AF with elevated HRs led to haemodynamic deterioration. A resting mean MVPG > 5 mmHg after PMVR has been associated with worse clinical outcome.8 However, MVPG may further increase during exercise or altered haemodynamics.9 Herein, we demonstrated that HR directly correlates with MV gradients after PMVR. Elevated MVPG directly translated into increased pulmonary pressures as demonstrated by RVSP measurements. Therefore, increases in MVPG during AF with rapid ventricular response may lead to dyspnoea on exertion or left heart decompensation with pulmonary congestion. While the relationship between HR and native MVPG is well known,10 there is currently no evidence about this haemodynamic association after PMVR. Stroke volume decreases when HR increases, but HR augmentation compensated that drop in stroke volume in terms of cardiac output. The impairment of both GLS and stroke volume during HR augmentation appears contrary to the physiologic force–frequency relationship (Bowditch effect) in healthy hearts.11 However, both are load‐dependent parameters of LV ejection and do not reflect LV contractility.12 In patients after PMVR with elevated MVPG, the decrease in GLS may relate to reduced LV diastolic filling rather than impaired myocardial performance.13 We have recently demonstrated that worsening GLS after PMVR is related to the elimination of the regurgitation volume whereas LV contractility was preserved, confirming that GLS is indeed load dependent.1 This case report shows that GLS after PMVR depends on HR, indicating that HR should be documented along with GLS and taken into account when interpreting GLS values. This haemodynamic study indicates that AF with rapid ventricular response can significantly contribute to haemodynamic impairment after PMVR. In heart failure patients with uncontrolled HR despite medical treatment, cardiac resynchronization therapy combined with AV node ablation is recommended by current guidelines (level of recommendation, IIa).14, 15 Since the patient was allocated to PMVR due to prohibitive risk for surgical MV repair, reduction of heart failure symptoms and prevention of recurrent cardiac decompensations were the primary treatment goal. Therefore, the invasive strategy with AV node ablation was deemed appropriate. Within this strategy, a cardiac resynchronization therapy and pacemaker system was chosen in agreement with the patient. Despite the fact that the anatomic MV orifice is unaffected by this treatment, transvalvular haemodynamics, LV performance, and pulmonary pressures can be improved by rate control. In addition, continuous biventricular pacing may cause beneficial effects in patients with left bundle branch block and signs of LV dyssynchrony. Since this is a case report with inherent limitations, all haemodynamic correlations with HR have to be confirmed by larger studies. This applies particularly for the association of MVPG and RVSP because both factors depend on HR as the independent variable.

Conclusions

Elevated transmitral pressure gradients following PMVR that occur during AF with rapid ventricular response can contribute to cardiac decompensation. Ventricular rate control by His‐bundle ablation and subsequent biventricular pacing appears feasible in patients with elevated MVPGs and may be considered when HR during AF remains insufficiently controlled.

Conflict of interest

None declared.
  15 in total

Review 1.  Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice.

Authors:  Helmut Baumgartner; Judy Hung; Javier Bermejo; John B Chambers; Arturo Evangelista; Brian P Griffin; Bernard Iung; Catherine M Otto; Patricia A Pellikka; Miguel Quiñones
Journal:  Eur J Echocardiogr       Date:  2008-12-08

2.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

Authors:  Michele Brignole; Angelo Auricchio; Gonzalo Baron-Esquivias; Pierre Bordachar; Giuseppe Boriani; Ole-A Breithardt; John Cleland; Jean-Claude Deharo; Victoria Delgado; Perry M Elliott; Bulent Gorenek; Carsten W Israel; Christophe Leclercq; Cecilia Linde; Lluís Mont; Luigi Padeletti; Richard Sutton; Panos E Vardas; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Paulus Kirchhof; Carina Blomstrom-Lundqvist; Luigi P Badano; Farid Aliyev; Dietmar Bänsch; Helmut Baumgartner; Walid Bsata; Peter Buser; Philippe Charron; Jean-Claude Daubert; Dan Dobreanu; Svein Faerestrand; David Hasdai; Arno W Hoes; Jean-Yves Le Heuzey; Hercules Mavrakis; Theresa McDonagh; Jose Luis Merino; Mostapha M Nawar; Jens Cosedis Nielsen; Burkert Pieske; Lidija Poposka; Frank Ruschitzka; Michal Tendera; Isabelle C Van Gelder; Carol M Wilson
Journal:  Eur Heart J       Date:  2013-06-24       Impact factor: 29.983

3.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur J Heart Fail       Date:  2016-05-20       Impact factor: 15.534

4.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Authors:  Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castella; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas; Stefan Agewall; John Camm; Gonzalo Baron Esquivias; Werner Budts; Scipione Carerj; Filip Casselman; Antonio Coca; Raffaele De Caterina; Spiridon Deftereos; Dobromir Dobrev; José M Ferro; Gerasimos Filippatos; Donna Fitzsimons; Bulent Gorenek; Maxine Guenoun; Stefan H Hohnloser; Philippe Kolh; Gregory Y H Lip; Athanasios Manolis; John McMurray; Piotr Ponikowski; Raphael Rosenhek; Frank Ruschitzka; Irina Savelieva; Sanjay Sharma; Piotr Suwalski; Juan Luis Tamargo; Clare J Taylor; Isabelle C Van Gelder; Adriaan A Voors; Stephan Windecker; Jose Luis Zamorano; Katja Zeppenfeld
Journal:  Eur J Cardiothorac Surg       Date:  2016-09-23       Impact factor: 4.191

5.  Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II.

Authors:  Ted Feldman; Saibal Kar; Sammy Elmariah; Steven C Smart; Alfredo Trento; Robert J Siegel; Patricia Apruzzese; Peter Fail; Michael J Rinaldi; Richard W Smalling; James B Hermiller; David Heimansohn; William A Gray; Paul A Grayburn; Michael J Mack; D Scott Lim; Gorav Ailawadi; Howard C Herrmann; Michael A Acker; Frank E Silvestry; Elyse Foster; Andrew Wang; Donald D Glower; Laura Mauri
Journal:  J Am Coll Cardiol       Date:  2015-12-29       Impact factor: 24.094

6.  Strain, strain rate, and the force frequency relationship in patients with and without heart failure.

Authors:  Susanna Mak; Harriette G C Van Spall; Rodrigo V Wainstein; Zion Sasson
Journal:  J Am Soc Echocardiogr       Date:  2011-12-03       Impact factor: 5.251

7.  Elevated Mitral Valve Pressure Gradient After MitraClip Implantation Deteriorates Long-Term Outcome in Patients With Severe Mitral Regurgitation and Severe Heart Failure.

Authors:  Michael Neuss; Thomas Schau; Akihiro Isotani; Markus Pilz; Maren Schöpp; Christian Butter
Journal:  JACC Cardiovasc Interv       Date:  2017-05-08       Impact factor: 11.195

8.  Comparison of Percutaneous Mitral Valve Repair Versus Conservative Treatment in Severe Functional Mitral Regurgitation.

Authors:  Cristina Giannini; Francesca Fiorelli; Marco De Carlo; Fabio Guarracino; Michela Faggioni; Paolo Giordano; Paolo Spontoni; Andrea Pieroni; Anna Sonia Petronio
Journal:  Am J Cardiol       Date:  2015-11-06       Impact factor: 2.778

9.  Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry.

Authors:  Georg Nickenig; Rodrigo Estevez-Loureiro; Olaf Franzen; Corrado Tamburino; Marc Vanderheyden; Thomas F Lüscher; Neil Moat; Susanna Price; Gianni Dall'Ara; Reidar Winter; Roberto Corti; Carmelo Grasso; Thomas M Snow; Raban Jeger; Stefan Blankenberg; Magnus Settergren; Klaus Tiroch; Jan Balzer; Anna Sonia Petronio; Heinz-Joachim Büttner; Federica Ettori; Horst Sievert; Maria Giovanna Fiorino; Marc Claeys; Gian Paolo Ussia; Helmut Baumgartner; Salvatore Scandura; Farqad Alamgir; Freidoon Keshavarzi; Antonio Colombo; Francesco Maisano; Henning Ebelt; Patrizia Aruta; Edith Lubos; Björn Plicht; Robert Schueler; Michele Pighi; Carlo Di Mario
Journal:  J Am Coll Cardiol       Date:  2014-09-02       Impact factor: 24.094

10.  Early Hemodynamic Improvement after Percutaneous Mitral Valve Repair Evaluated by Noninvasive Pressure-Volume Analysis.

Authors:  Daniel Lavall; Jan-Christian Reil; Lucia Segura Schmitz; Manuel Mehrer; Stephan H Schirmer; Michael Böhm; Ulrich Laufs
Journal:  J Am Soc Echocardiogr       Date:  2016-06-29       Impact factor: 5.251

View more
  3 in total

1.  Impact of simulated MitraClip on forward flow obstruction in the setting of mitral leaflet tethering: An in vitro investigation.

Authors:  Charles H Bloodworth; Eric L Pierce; Keshav Kohli; Nancy J Deaton; Kaitlin J Jones; Radhika Duvvuri; Norihiko Kamioka; Vasilis C Babaliaros; Ajit P Yoganathan
Journal:  Catheter Cardiovasc Interv       Date:  2018-08-09       Impact factor: 2.692

2.  Mitral valve pressure gradient after percutaneous mitral valve repair: every beat counts.

Authors:  Daniel Lavall; Bruno Scheller; Christian Werner; Axel Buob; Felix Mahfoud
Journal:  ESC Heart Fail       Date:  2017-11-23

Review 3.  Mitral valve interventions in heart failure.

Authors:  Daniel Lavall; Andreas Hagendorff; Stephan H Schirmer; Michael Böhm; Michael A Borger; Ulrich Laufs
Journal:  ESC Heart Fail       Date:  2018-04-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.